LIVER: The gut is a key target of therapy in hepatic encephalopathy

    loading  Checking for direct PDF access through Ovid

Abstract

Little progress has been made in the pharmacological management of patients with hepatic encephalopathy, partly because it is difficult to perform clinical trials in this group of patients. A new clinical trial now suggests that polyethylene glycol is more effective than the current standard first-line therapy in these patients.

Related Topics

    loading  Loading Related Articles